Issue Type: Balancing Innovation, Value, and Drug Prices

does this show up on site? or is this internal?
in challenge narrative

  • Ethics of Clinical Trials to Evaluate Biosimilars

  • Bottom-Up Pricing Estimate for P-quad

  • Modeling P-quad

  • Balancing Innovation and Drug Pricing

  • Who Is Sowing Seeds of Confusion About The QALY?

  • Before Spending Billions, U.S. Hospitals Need to Study Remdesivir Further

  • Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

  • Dissecting PhRMA’s Opposition to H.R. 3 Lower Drug Costs Now Act of 2019

  • Time to Throw in the Towel on Biosimilars

  • Dr. Bach Testifies at U.S. Senate Committee on Finance’s First Hearing of Session

    Dr. Bach Testifies at U.S. Senate Committee on Finance’s First Hearing of Session